Distinguishing and Managing Early-Stage Alzheimer’s Disease (AD): Leveraging Interdisciplinary Collaboration for Prompt Identification and Optimal Patient Management
Clinical Conversation Series
Pre-test

Questions marked with a * are required
100%
Contact Information
A 67-year-old woman presents with up to 7 years of memory complaints. She asks repetitive questions about plans, is nervous while driving, and is very worried and anxious about her memory as her mother developed dementia in her late 60’s. She has struggled with worsening depression and sleep difficulty over the past 3 years. MMSE = 26/30 (missed two orientation and two memory recall questions); she can encode and recall 4/5 elements of an address; and has good knowledge of current and personal events, with a few inaccuracies and forgetfulness with details and timing. All else, including activities of daily living, is unremarkable. How would you diagnose this patient? 
Choosing initial treatment for mild cognitive impairment or Alzheimer’s disease, and continuing or altering subsequent treatment should always include which of the following?
Which of the following is true regarding multidisciplinary care for patients with Alzheimer’s disease? 
A 77-year-old man was diagnosed with MCI 5 years ago and has progressed to mild dementia likely due to AD. He asks if there are treatment options that may help delay future cognitive decline, specifically bringing up disease-modifying therapy. You discuss the potential future use of amyloid-targeting treatments, which the patient is interested in pursuing. Which of the following points are important to make when considering disease-modifying therapy for this patient? 
Which of the following would most frequently fall under the care of a neurologist or subspecialist, while the others could readily be conducted by primary care clinicians?
Powered by QuestionPro